4//SEC Filing
Robinson Byron 4
Accession 0001209191-22-015616
CIK 0001817713other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 5:06 PM ET
Size
5.4 KB
Accession
0001209191-22-015616
Insider Transaction Report
Form 4
Robinson Byron
Chief Strategy Officer
Transactions
- Award
Stock Option (right to buy)
2022-03-01+230,000→ 230,000 totalExercise: $16.81Exp: 2032-02-29→ Common Stock (230,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vest on February 28, 2023 and the balance will vest in equal monthly installments thereafter over a three year period.
Documents
Issuer
Janux Therapeutics, Inc.
CIK 0001817713
Entity typeother
Related Parties
1- filerCIK 0001914899
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 5:06 PM ET
- Size
- 5.4 KB